ERIN MCGEACHIE: Open Payments
NPI 1801452149 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 59 payments from 10 companies in 2025. Trend: 2023 $989 · 2024 $328 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $308 |
| ABBVIE INC. | 19 | $243 |
| Alkermes, Inc. | 7 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Janssen Pharmaceuticals, Inc | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $18 |
Products named: COBENFY, VRAYLAR, ARISTADA, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, CAPLYTA, UZEDY.
Industry payments across SC — which companies pay providers there.
